Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 28.

Opitz, I; Weder, W (2018). Pleural mesothelioma: is the surgeon still there? Annals of Oncology, 29(8):1710-1717.

Kostron, A; Horn-Tutic, M; Franzen, D; Kestenholz, P; Schneiter, D; Opitz, I; Kohler, M; Weder, W (2015). Repeated lung volume reduction surgery is successful in selected patients. European Journal of Cardio-Thoracic Surgery, 48(5):710-715.

Opitz, I; Bueno, R; Lim, E; Pass, H; Pastorino, U; Boeri, M; Rocco, G; ESTS Biology Club (2014). Biomolecular and clinical practice in malignant pleural mesothelioma and lung cancer: what thoracic surgeons should know. European Journal of Cardio-Thoracic Surgery, 46(4):602-606.

Brunelli, A; Falcoz, P E; D'Amico, T; Hansen, H; Lim, E; Massard, G; Rice, T W; Rocco, G; Thomas, P; Van Raemdonck, D; Congregado, M; Decaluwe, H; Grodzki, T; Lerut, T; Molnar, T; Salati, M; Scarci, M; Van Schil, P; Varela, G; Venuta, F; Melfi, F; Gebitekin, C; Kuzdzal, J; Leschber, G; Opitz, I; Papagiannopoulos, K; Patterson, A; Ruffini, E; Klepetko, W; Toker, A (2014). European guidelines on structure and qualification of general thoracic surgery. European Journal of Cardio-Thoracic Surgery, 45(5):779-786.

Otterstrom, C; Soltermann, A; Opitz, I; Felley-Bosco, E; Weder, W; Stahel, R A; Triponez, F; Robert, J H; Serre-Beinier, V (2014). CD74: a new prognostic factor for patients with malignant pleural mesothelioma. British Journal of Cancer, 110(8):2040-2046.

Inci, I; Schuurmans, M M; Kestenholz, P; Schneiter, D; Hillinger, S; Opitz, I; Boehler, A; Weder, W (2013). Long-term outcomes of bilateral lobar lung transplantation. European Journal of Cardio-Thoracic Surgery, 43(6):1220-1225.

Opitz, I; Weder, W (2012). Diagnostik und Therapie des malignen Pleuramesothelioms - von der Palliationzur kurativen Intention. Therapeutische Umschau. Revue thérapeutique, 69(7):401-5.

Felley-Bosco, E; Opitz, I; Soltermann, A; Thies, S; Weder, W; Stahel, R A (2011). Asbestos-induced tissue regeneration and malignant pleural mesothelioma: Insights from developmental studies. In: Berhardt, L V. Advances in Medicine and Biology. Volume 34. Hauppauge NY, USA: Nova Science Publishers, 131-153.

Arbogast, S; Behnke, S; Opitz, I; Stahel, R A; Seifert, B; Weder, W; Moch, H; Soltermann, A (2011). Automated ERCC1 Immunohistochemistry in Non-small Cell Lung Cancer: Comparison of anti-ERCC1 Antibodies 8F1, D-10, and FL-297. Applied Immunohistochemistry & Molecular Morphology, 19(2):99-105.

Busacca, S; Sheaff, M; Arthur, K; Gray, S G; O'Byrne, K J; Richard, D J; Soltermann, A; Opitz, I; Pass, H; Harkin, D P; Quinn, J E; Fennell, D A (2011). BRCA1 is an essential mediator of vinorelbine induced apoptosis in mesothelioma. Journal of Pathology:1-28.

Shi, Y; Hollenstein, A; Felley-Bosco, E; Fraefel, C; Ackermann, M; Soltermann, A; Weder, W; Stahel, R A; Pruschy, M; Opitz, I (2011). Bioluminescence imaging for in vivo monitoring of local recurrence mesothelioma model. Lung Cancer, 71(3):370-371.

Sidi, R; Pasello, G; Opitz, I; Soltermann, A; Tutic, M; Rehrauer, H; Weder, W; Stahel, R A; Felley-Bosco, E (2011). Induction of senescence markers after neo-adjuvant chemotherapy of malignant pleural mesothelioma and association with clinical outcome: an exploratory analysis. European Journal of Cancer, 47(2):326-332.

Opitz, I; Erne, B V; Demirbas, S; Jetter, A; Seifert, Burkhardt; Stahel, R; Weder, W (2011). Optimized intrapleural cisplatin chemotherapy with a fibrin carrier after extrapleural pneumonectomy: a preclinical study. Journal of Thoracic and Cardiovascular Surgery, 141(1):65-71.

Frei, C; Opitz, I; Soltermann, A; Fischer, B; Moura, U; Rehrauer, H; Weder, W; Stahel, R; Felley-Bosco, E (2011). Pleural mesothelioma side populations have a precursor phenotype. Carcinogenesis, 32(9):1324-1332.

Frauenfelder, T; Tutic, M; Weder, W; Götti, R P; Stahel, R A; Seifert, Burkhardt; Opitz, I (2011). Volumetry - an alternative to assess therapy response for malignant pleural mesothelioma? European Respiratory Journal, 38(1):162-168.

Schramm, A; Opitz, I; Thies, S; Seifert, B; Moch, H; Weder, W; Soltermann, A (2010). Prognostic significance of epithelial-mesenchymal transition in malignant pleural mesothelioma. European Journal of Cardio-Thoracic Surgery, 37(3):566-572.

Soltermann, A; Opitz, I; Tischler, V; Thies, S; Morra, L; Stahel, R A; Weder, W; Moch, H (2010). EMT in NSCLC and malignant pleural mesothelioma. memo - Magazine of European Medical Oncology, 3(4):180-184.

Fritzsche, F R; Tutic, M; Opitz, I; Hunziker, R; Kristiansen, G; Montani, M (2010). Pulmonary Kaposi's sarcoma after heart transplantation: a case report. Journal of Medical Case Reports, 4:206.

Fritzsche, F R; Kristiansen, G; Frauenfelder, T; Opitz, I; Bode, P; Moch, H; Montani, M (2009). Large mixed germ cell tumor in a young patient presenting as an intrapulmonary mass. Pathology - Research and Practice, 205(8):572-578.

Thurneysen, C; Opitz, I; Kurtz, S; Weder, W; Stahel, R A; Felley-Bosco, E (2009). Functional inactivation of NF2/merlin in human mesothelioma. Lung Cancer, 64(2):140-147.

Ampollini, L; Soltermann, A; Felley-Bosco, E; Lardinois, D; Arni, S; Speck, R F; Weder, W; Opitz, I (2009). Immuno-chemotherapy reduces recurrence of malignant pleural mesothelioma: an experimental setting. European Journal of Cardio-Thoracic Surgery, 35(3):457-462.

Stahel, R A; Felley-Bosco, E; Opitz, I; Weder, W (2009). Malignant pleural mesothelioma. Future Oncology, 5(3):391-402.

Weder, W; Opitz, I; Stahel, R (2009). Multimodality strategies in malignant pleural mesothelioma. Seminars in Thoracic and Cardiovascular Surgery, 21(2):172-176.

Moser, C; Opitz, I; Zhai, W; Rousson, V; Russi, E W; Weder, W; Lardinois, D (2008). Autologous fibrin sealant reduces the incidence of prolonged air leak and duration of chest tube drainage after lung volume reduction surgery: a prospective randomized blinded study. Journal of Thoracic and Cardiovascular Surgery, 136(4):843-849.

Stahel, R; Felley-Bosco, E; Opitz, I; Weder, W (2008). Mesothelioma. In: Hansen, H. Lung Cancer Therapy Annual 6. New York: Informa Healthcare USA, Inc., 205-222.

Opitz, I; Soltermann, A; Abaecherli, M; Hinterberger, M; Probst-Hensch, N; Stahel, R; Moch, H; Weder, W (2008). PTEN expression is a strong predictor of survival in mesothelioma patients. European Journal of Cardio-Thoracic Surgery, 33(3):502-506.

Opitz, I; Kestenholz, P; Lardinois, D; Müller, M; Rousson, V; Schneiter, D; Stahel, R; Weder, W (2006). Incidence and management of complications after neoadjuvant chemotherapy followed by extrapleural pneumonectomy for malignant pleural mesothelioma. European Journal of Cardio-Thoracic Surgery, 29(4):579-584.

Lardinois, D; Jung, F J; Opitz, I; Rentsch, K; Latkoczy, C; Vuong, V; Varga, Z; Rousson, V; Günther, D; Bodis, S; Stahel, R; Weder, W (2006). Intrapleural topical application of cisplatin with the surgical carrier Vivostat increases the local drug concentration in an immune-competent rat model with malignant pleuromesothelioma. Journal of Thoracic and Cardiovascular Surgery, 131(3):697-703.

This list was generated on Wed Jun 26 15:11:32 2019 CEST.